Fenwick Guides Passage Bio In Upsized, $216M Debut
Passage Bio started trading Friday after raising $216 million in an upsized initial public offering steered by Fenwick & West LLP that saw the genetic medicine company price at the top...To view the full article, register now.
Already a subscriber? Click here to view full article